Condition
Rectal Lesion
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Active Not Recruiting1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06133387Not ApplicableRecruiting
PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System
NCT05476263Recruiting
Suprasorb® CNPendo Used for Negative Pressure Therapy in the Oesophagus and Rectum to Support Defect and Wound Healing
NCT06286956Not ApplicableActive Not Recruiting
Rectal Tumor Resection Using the UNI-VEC Multichannel Transanal Access Device
NCT04651764Not ApplicableTerminated
Transanal Resection of Rectal Lesions With the ColubrisMX ELS System
Showing all 4 trials